180 results
8-K
EX-10.1
LXRX
Lexicon Pharmaceuticals Inc
11 Mar 24
Lexicon Pharmaceuticals Reports Fourth Quarter 2023
7:26am
financial responsibility against such losses and risks and in such amounts as are prudent and customary in the businesses in which it is engaged. The Company … of the Agreement and (c) the Placement Agents will not have any responsibility with respect to (i) any representations, warranties or agreements made by any
8-K
EX-1.1
aphabwhguprnuepxpz
29 Dec 23
Entry into a Material Definitive Agreement
5:29pm
424B5
1myz7fd4j
29 Dec 23
Prospectus supplement for primary offering
5:27pm
8-K
EX-1.1
1bk0mav dl
2 Jun 23
Lexicon Announces Pricing of $125 Million Public Offering and Concurrent Private Placement
4:31pm
424B5
5lq88s8tkkh2o061ee
1 Jun 23
Prospectus supplement for primary offering
9:08pm
424B5
vbz6jguo9 2s
31 May 23
Prospectus supplement for primary offering
4:07pm
8-K
EX-1.1
s2ack4j1usx
29 Jul 22
Lexicon Announces Proposed Public Offering of Common Stock
5:18pm
424B5
8zm0 laud
29 Jul 22
Prospectus supplement for primary offering
8:12am
424B5
drskv p1ozbqi
27 Jul 22
Prospectus supplement for primary offering
5:30pm
CORRESP
umnm vdim6g6e88oum0o
10 Sep 21
Correspondence with SEC
12:00am